Literature DB >> 1184317

Studies of aqueous humor dynamics in man. IV. Effects of pilocarpine upon measurements in young normal volunteers.

D Gaasterland, C Kupfer, K Ross.   

Abstract

The acute effects of topical pilocarpine 4 per cent, administered to one eye, have been studied in replicate experiments in young volunteers. One hour after medication administration the intraocular pressure was significantly lower. The magnitude of the reduction exceeded that predicated from the significant increase of true facility of outflow. This is explained by the observation of a significant reduction of calculated aqueous humor flow. Pilocarpine caused a significant increase of pseudofacility, a clinically useful drug effect not previously reported. One hour after medication administration, measured episcleral venous pressure was not different from the pretreatment level.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1184317

Source DB:  PubMed          Journal:  Invest Ophthalmol        ISSN: 0020-9988


  5 in total

Review 1.  The flow of aqueous humor in the human eye.

Authors:  R F Brubaker
Journal:  Trans Am Ophthalmol Soc       Date:  1982

2.  Effects of pilocarpine on the morphology of the human outflow apparatus.

Authors:  I Grierson; W R Lee; S Abraham
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

3.  Topical atenolol versus pilocarpine: a double-blind study of the effect on ocular tension.

Authors:  K Wettrell; K Wilke; M Pandolfi
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

4.  Intraocular pressure reduction during treatment with pilocarpine and systemic propranolol. A comparative double-masked study.

Authors:  K Wettrell
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-09-30

5.  Ocular hypotensive effects of a Rho-associated protein kinase inhibitor in rabbits.

Authors:  Muhammad Irfan Kamaruddin; Momoko Nakamura-Shibasaki; Yu Mizuno; Yoshiaki Kiuchi
Journal:  Clin Ophthalmol       Date:  2017-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.